Glioblastoma multiforme: A case study

Internet Journal of Advanced Nursing Practice

Volumn 9, Issue 2, 2008, Pages

  Bachuss, Christopher A ^a,b  

^a Columbia University ^*

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149498373     PISSN: None     EISSN: 15236064     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dale, D.C., Fauci, A.S., Guerry, D., Wolff, S.M. Comparison of agents producing a neutrophilic leukocytosis in man. J Clin Invest 1975; 56: 808-13.
2. Central Brain Tumor Registry of the United States. 2005-2006 statistical report tables. [online] 2008. Available at: http://www.cbtrus.org/reports//2005- 2006/2006report.pdf
3. Stupp, R., Mason, W.P., Van Den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J.B, Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., Mirimanoff, R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. NEJM 2005; 352: 987-96.
4. DeAngelis, L.M., Gutin, P.H., Leibel, S.A., Posner, J.B. Intracranial tumors: Diagnosis and treatment. London: Martin Dunitz; 2002.
5. Colvin, M. Alkylating Agents and Platinum Antitumor Compounds. In: Kufe, D.W., Bast, R.C., Hait, W.N., Hong, W.K., Pollock, R.E., Weichselbaum, R.R., Holland, J.F., Frei, E., editors. Holland-Frei Cancer Medicine. Hamilton, Ontario: B.C. Becker; 2006.
6. Bower, M., Newlands, E.S., Bleehen, N.M., Brada, M., Begent, R.J.H., Calvert, H., Colquhoun, I., Lewis, P., Brampton, M.H. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 1997; 40: 484-8.
7. Mason, W.P., Maestro, R.D., Eisenstat, D., Forsyth, P., Fulton, D., Laperrière, N., Macdonald, D., Perry J., Thiessen, B.; for the Canadian GBM Recommendations Committee. Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 2007; 14: 110-7.
8. American Society of Health-System Specialists. AHFS Drug Information. In: McEvoy, G.K., Snow, E.K., editors. AHFS Drug Information 2008. Available at: http://online.statref.com/Document/Document.aspx?FxId=1&StartDoc= 627&EndDoc=627&Level=5&Offset=44amp;State=False&SessionId= C0F46DEKCKTZLPJL
9. Anderson, L.A. Drug class overviews: Antiemetics. Clinical Pharmacology. Available at: http://www.clinicalpharmacology-ip.com/Forms/Resources/overviews. aspx?oid=7
10. Kris, M.G., Hesketh, P.J, Somerfield, M.R., Feyer, P., Clark-Snow, R., Koeller, J.M., Morrow, G.R., Chinnery, L.W., Chesney, M.J., Gralla, R.J., Grunberg, S.M. American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006. J Clin Oncol 2006; 24: 2932-47.
11. Ondansetron. Micromedex. [online] 2008. Available at: http://www.thomsonhc.com/hcs/librarian/ND-T/HCS/ND-PR/Main/CS/C0189E/ DUPLICATIONS20/SearchOption/BeginWith
12. Bleiberg HH, Spielmann M, Falkson G, Romain, D. Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: a dose ranging study. Clin Therapeut 1995; 17: 38-50.
13. Rubenstein EB, Gralla RJ, & Hainsworth JD: Randomized, double-blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Cancer 1997; 79: 1216-24.
14. Maldonado, F., Limper, A.H., Lim, K.G., Aubry, M.C. Temozolomide- associated organizing pneumonitis. Mayo Clin Proc 2007; 82: 771-3.
15. Abrey, L.E., Olson, J.D., Raizer, J.J., Mack, M., Rodavitch, A., Boutros, D.Y., Malkin, M.G. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 2001; 53: 259-65.
16. Brandes, A.A., Tosoni, A., Cavallo, G., Bertorelle, R., Gioia, V., Franceschi, E, Biscuola, M., Blatt, V., Crino, L., Emani, M. Temozolomide 3 weeks on and 1 week off as first- line therapy for recurrent glioblastoma: Phase II study from gruppo italiano cooperativo di neurooncologia (GICNO). Br J Cancer 2006; 95: 1155-60.
17. Ioannidis, J.P., Cappelleri, J.C., Skolnik, P.R., Lau, J., Sacks, H.S. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 1996; 156: 177-88.
18. El-Sadr, W.M., Luskin-Hawk, R., Yurik, T.M., Walker, J., Abrams, D., John, S.L., Sherer, R., Crane, L., Labriola, A., Caras, S., Pulling, C., Hafner, R. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Clin Infect Dis 1999; 29: 775-83.
19. Dexamethasone. Micromedex. [online] 2008. Available at: http://www.thomsonhc.com/hcs/librarian/ND-PR/Main/SBK/11/PFPUI/ Gv1exME2eYtci%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20% 20%20%20%20%20%20%20%20r/ND-PG/PRIH/CS/DF7994/ND-T/HCS/ND-P/Main/ DUPLICATIONSHIELDSYNC/B% 2040D1C/ND-B/HCS/PFActionId/hcs.common. RetrieveDocumentCommon/DocId/171860%20/ContentSetId/100/SearchTerm/ dexamethasone%20/SearchOption/BeginWith
20. Wen, P.Y., Schiff, D. Kesari, S., Drappatz, J., Gigas, D.C., Doherty, L. Medical management of patients with brain tumors. J Neurooncol 2006 80: 313-32.
21. O'Laoire, S.A. Epilepsy following neurosurgical intervention. Acta Neurochir 1990; 50: 52-4.
22. Wang, E.C., Geyer, J.R., Berger, M.S. Incidence of postoperative epilepsy in children following subfrontal craniotomy for tumor. Pediatr Neurosurg 1994; 21: 172-3.
23. Baker, C.J., Prestigiacomo, C.J., Solomon, R.A. Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery 1995; 37: 870-1.
24. Hayashi, T., Hadeishi, H., Kawamura, S., Nonoyama, Y., Suzuki, A., Yasui, N. Postoperative anticonvulsant prophylaxis for patients treated for cerebral aneurysms. Neurol Med Chir 1999; 39: 828-33.
25. Aguiar, D., Pazo, R., Duran, I., Terrasa, J., Arrivi, A., Manzano, H., Martin, J., Rifa, J. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neuro oncol 2004; 66: 345-50.
26. Ranganathan LN, Ramaratnam S. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database of Systematic Reviews 2006.
27. Temozolomide. Micromedex. [online] 2008. Available at: http://www.thomsonhc.com/hcs/librarian/ND-T/HCS/ND-PR/Main/CS/2AF8A5/ DUPLICATIONS